Real-life scientists have recently developed a true “enhance” tool: one that improves the resolution and accuracy of powerful […]
The Engineering Design and Technological Development Group (DIDET), from the University of AlicanteArtefactosLAB, has once again taken a […]
In general practice, waiting rooms are quiet, there are fewer locums, and, for now at least, the Care […]
Covid-19 has been a dramatic global health and economic shock. As SARS-CoV-2 spread across nations, economic activity plummeted, […]
US drug prices are the highest in the world and are continuing to rise, with an increasing number […]
History will remember 2020 as the year when the covid-19 pandemic plunged the world into turmoil, leaving climate […]
I, too, am deeply concerned about the secondary harms inflicted on patients and families by blanket restrictions.1 As […]
Updated Date: Wed, 30 Sep 2020 00:00:00 EDT
Twenty charities representing people affected by rare and less common cancers launch ’20 for 20′ campaign
Senior leaders from patient organisations and the pharma industry came together to discuss best practice in patient partnerships